慢性B型肝炎新合併療法:植物新藥BEL-X

Novel Combination Treatment for Chronic Hepatitis B: Botanical New Drug BEL-X
BEL-X可大幅縮短B肝患者服藥時間及增加e抗原轉陰率,且可降低停藥後病毒復發率。
項目技術源自國家研究單位,經二十多年研發,建立了六大核心技術,包含細胞生物學、分子生物學、藥理毒理、臨床試驗、GACP農業、專利。在未來,BEL-X將提供病患有效且安全之療法,並因應國際情勢而發展自主供應鏈,以求達醫療自主及國家衛生安全之需求。
BEL-X not only shorten the treatment duration but also increase HBe seroconversion rate, and reduce viral rebound after stopping treatment of HBV patients.
The technologies of this project originates from national research institutes, and after more than 20 years of research and development, we have established six core technologies including cell biology, molecular biology, pharmacology and toxicology, clinical trial, pharmaceutical science, GACP agriculture, and patents. BEL-X will provide effective and safe treatment for patients in the future, and develop localized supply chain in response to the international situation, which will achieve medical independent and national security of health and safety.